Caspase Inhibition in Islet Transplantation

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2012 by University of Alberta
Sponsor:
Collaborator:
Conatus Pharmaceuticals Inc.
Information provided by (Responsible Party):
James Shapiro, University of Alberta
ClinicalTrials.gov Identifier:
NCT01653899
First received: July 12, 2012
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)